Variant report

Variant	nsv1043338
Chromosome Location	chr10:27607905-27702509
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1088)
CpG islands
(count:793)
Chromatin interactive
region (count:23)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:1088 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:27672857-27673169	HepG2	liver:	n/a	n/a
2	ARID3A	chr10:27649547-27649808	K562	blood:	n/a	n/a
3	ARID3A	chr10:27629946-27630482	HepG2	liver:	n/a	n/a
4	ATF1	chr10:27649531-27649804	K562	blood:	n/a	n/a
5	BATF	chr10:27633841-27634192	GM12878	blood:	n/a	n/a
6	BATF	chr10:27649564-27649764	GM12878	blood:	n/a	n/a
7	BATF	chr10:27643692-27643988	GM12878	blood:	n/a	n/a
8	BCL11A	chr10:27643724-27643987	GM12878	blood:	n/a	n/a
9	BCL11A	chr10:27643658-27644039	GM12878	blood:	n/a	n/a
10	BCL3	chr10:27672617-27673252	A549	lung:	n/a	n/a
11	BCLAF1	chr10:27643572-27643923	GM12878	blood:	n/a	n/a
12	BHLHE40	chr10:27672558-27673044	HepG2	liver:	n/a	n/a
13	BHLHE40	chr10:27649567-27649799	K562	blood:	n/a	n/a
14	BHLHE40	chr10:27646116-27646388	K562	blood:	n/a	chr10:27646219-27646232 chr10:27646221-27646230 chr10:27646222-27646231 chr10:27646221-27646230
15	BHLHE40	chr10:27649517-27649830	GM12878	blood:	n/a	n/a
16	BHLHE40	chr10:27633890-27634818	GM12878	blood:	n/a	n/a
17	BRCA1	chr10:27672817-27673127	Hela-S3	cervix:	n/a	n/a
18	CBX3	chr10:27681602-27681815	K562	blood:	n/a	n/a
19	CBX3	chr10:27681617-27681837	K562	blood:	n/a	n/a
20	CCNT2	chr10:27649596-27649806	K562	blood:	n/a	n/a
21	CCNT2	chr10:27639061-27639239	K562	blood:	n/a	n/a
22	CEBPB	chr10:27684721-27685002	Hela-S3	cervix:	n/a	chr10:27684883-27684896
23	CEBPB	chr10:27677675-27678050	Hela-S3	cervix:	n/a	chr10:27677849-27677860
24	CEBPB	chr10:27634283-27634772	Hela-S3	cervix:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
25	CEBPB	chr10:27649533-27649818	A549	lung:	n/a	chr10:27649675-27649686
26	CEBPB	chr10:27634266-27634780	HepG2	liver:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
27	CEBPB	chr10:27608939-27609321	ECC-1	luminal epithelium:	n/a	chr10:27609272-27609283 chr10:27609201-27609212 chr10:27609124-27609137
28	CEBPB	chr10:27634350-27634708	IMR90	lung:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
29	CEBPB	chr10:27677736-27678037	IMR90	lung:	n/a	chr10:27677849-27677860
30	CEBPB	chr10:27649513-27649869	IMR90	lung:	n/a	chr10:27649675-27649686
31	CEBPB	chr10:27672803-27673162	MCF-7	breast:	n/a	n/a
32	CEBPB	chr10:27672754-27673203	A549	lung:	n/a	n/a
33	CEBPB	chr10:27659541-27659772	HepG2	liver:	n/a	chr10:27659628-27659639 chr10:27659627-27659638 chr10:27659627-27659640
34	CEBPB	chr10:27677693-27677915	MCF-7	breast:	n/a	chr10:27677849-27677860
35	CEBPB	chr10:27608518-27609427	Hela-S3	cervix:	n/a	chr10:27609272-27609283 chr10:27609201-27609212 chr10:27609124-27609137
36	CEBPB	chr10:27662820-27663067	HepG2	liver:	n/a	chr10:27662910-27662921
37	CEBPB	chr10:27672755-27673183	A549	lung:	n/a	n/a
38	CEBPB	chr10:27609103-27609337	HepG2	liver:	n/a	chr10:27609272-27609283 chr10:27609201-27609212 chr10:27609124-27609137
39	CEBPB	chr10:27669848-27670363	HepG2	liver:	n/a	chr10:27669887-27669899
40	CEBPB	chr10:27608935-27609364	ECC-1	luminal epithelium:	n/a	chr10:27609272-27609283 chr10:27609201-27609212 chr10:27609124-27609137
41	CEBPB	chr10:27634311-27634682	A549	lung:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
42	CEBPB	chr10:27679600-27679898	Hela-S3	cervix:	n/a	n/a
43	CEBPB	chr10:27655050-27655300	K562	blood:	n/a	chr10:27655162-27655173 chr10:27655161-27655172 chr10:27655161-27655174
44	CEBPB	chr10:27649575-27649846	HepG2	liver:	n/a	chr10:27649675-27649686
45	CEBPB	chr10:27609089-27609311	A549	lung:	n/a	chr10:27609272-27609283 chr10:27609201-27609212 chr10:27609124-27609137
46	CEBPB	chr10:27662837-27663055	K562	blood:	n/a	chr10:27662910-27662921
47	CEBPB	chr10:27655035-27655235	HepG2	liver:	n/a	chr10:27655162-27655173 chr10:27655161-27655172 chr10:27655161-27655174
48	CEBPB	chr10:27672818-27673157	HepG2	liver:	n/a	n/a
49	CEBPB	chr10:27609087-27609339	K562	blood:	n/a	chr10:27609272-27609283 chr10:27609201-27609212 chr10:27609124-27609137
50	CEBPB	chr10:27653947-27654086	K562	blood:	n/a	n/a

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:27608703-27608753	IMR90	lung:	fetal
2	chr10:27609333-27609383	NB4	blood:	n/a
3	chr10:27698606-27698656	HPAEpiC	pulmonary alveolar:	n/a
4	chr10:27609163-27609213	CMK	blood:	n/a
5	chr10:27639136-27639186	HRCEpiC	kidney:	n/a
6	chr10:27609333-27609383	Caco-2	colon:	n/a
7	chr10:27639156-27639206	H1-hESC	embryonic stem cell:	embryo
8	chr10:27609286-27609336	HAEpiC	amniotic membrane:	n/a
9	chr10:27698606-27698656	LNCaP	prostate:	n/a
10	chr10:27609333-27609383	NHBE	bronchial:	n/a
11	chr10:27634719-27634769	AG10803	skin:	n/a
12	chr10:27608703-27608753	SK-N-SH_RA	brain:	n/a
13	chr10:27609286-27609336	HPAEpiC	pulmonary alveolar:	n/a
14	chr10:27607960-27608010	HCM	heart:	n/a
15	chr10:27698606-27698656	Jurkat	blood:	n/a
16	chr10:27609310-27609360	Hela-S3	cervix:	n/a
17	chr10:27608719-27608769	AG04449	skin:	fetal
18	chr10:27639156-27639206	SKMC	muscle:	n/a
19	chr10:27609310-27609360	RPTEC	kidney:	n/a
20	chr10:27609163-27609213	Caco-2	colon:	n/a
21	chr10:27608703-27608753	HepG2	liver:	n/a
22	chr10:27607960-27608010	NHBE	bronchial:	n/a
23	chr10:27608703-27608753	HUVEC	blood vessel:	n/a
24	chr10:27633745-27633795	LNCaP	prostate:	n/a
25	chr10:27607960-27608010	U87	brain:	n/a
26	chr10:27609333-27609383	AG10803	skin:	n/a
27	chr10:27609333-27609383	HCT-116	colon:	n/a
28	chr10:27609163-27609213	U87	brain:	n/a
29	chr10:27698606-27698656	T-47D	breast:	n/a
30	chr10:27608703-27608753	NH-A	brain:	n/a
31	chr10:27608719-27608769	HCM	heart:	n/a
32	chr10:27609333-27609383	GM12878	blood:	n/a
33	chr10:27698606-27698656	K562	blood:	n/a
34	chr10:27702309-27702359	SK-N-SH	brain:	n/a
35	chr10:27607960-27608010	GM19239	blood:	n/a
36	chr10:27634719-27634769	Caco-2	colon:	n/a
37	chr10:27607960-27608010	PrEC	prostate:	n/a
38	chr10:27633745-27633795	K562	blood:	n/a
39	chr10:27702309-27702359	NB4	blood:	n/a
40	chr10:27633745-27633795	AG04449	skin:	fetal
41	chr10:27702309-27702359	HAEpiC	amniotic membrane:	n/a
42	chr10:27639136-27639186	K562	blood:	n/a
43	chr10:27698606-27698656	HUVEC	blood vessel:	n/a
44	chr10:27609163-27609213	SKMC	muscle:	n/a
45	chr10:27633745-27633795	BE2_C	brain:	n/a
46	chr10:27639136-27639186	SKMC	muscle:	n/a
47	chr10:27609163-27609213	Hela-S3	cervix:	n/a
48	chr10:27634719-27634769	HCF	heart:	n/a
49	chr10:27609163-27609213	AG04450	lung:	fetal
50	chr10:27633745-27633795	GM06990	blood:	n/a

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:27527860..27530153-chr10:27647076..27648802,2	MCF-7	breast:
2	chr10:27681780..27685010-chr10:27685683..27688279,3	K562	blood:
3	chr10:27640371..27642415-chr10:27644846..27646556,2	K562	blood:
4	chr10:27659927..27662822-chr10:27662832..27664720,3	K562	blood:
5	chr10:27609103..27610966-chr10:27614340..27616128,2	K562	blood:
6	chr10:27441984..27445191-chr10:27642152..27645235,3	MCF-7	breast:
7	chr10:27694442..27697083-chr10:27703247..27705702,3	K562	blood:
8	chr10:27681780..27685010-chr10:27685683..27688279,3	K562	blood:
9	chr10:27659175..27661663-chr10:27792060..27794224,2	MCF-7	breast:
10	chr10:27684512..27686768-chr10:27700849..27702736,2	K562	blood:
11	chr10:26985698..26986799-chr10:27608358..27609419,4	HCT-116	colon:
12	chr10:27669052..27671269-chr10:27683257..27685068,2	K562	blood:
13	chr10:26984968..26988044-chr10:27607336..27609040,6	MCF-7	breast:
14	chr10:27607489..27609150-chr10:27638206..27640628,2	MCF-7	breast:
15	chr10:27659927..27662822-chr10:27662832..27664720,3	K562	blood:
16	chr10:26985474..26987624-chr10:27607358..27610341,4	MCF-7	breast:
17	chr10:27669052..27671269-chr10:27683257..27685068,2	K562	blood:
18	chr10:27609103..27610966-chr10:27614340..27616128,2	K562	blood:
19	chr10:27684512..27686768-chr10:27700849..27702736,2	K562	blood:
20	chr10:27530526..27532390-chr10:27644695..27646372,2	MCF-7	breast:
21	chr10:27529763..27532096-chr10:27643724..27645777,2	MCF-7	breast:
22	chr10:27640371..27642415-chr10:27644846..27646556,2	K562	blood:
23	chr10:27531028..27532588-chr10:27647976..27649755,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PTCHD3-1	chr10:27667067-27667291	NONHSAT011904
2	lnc-PTCHD3-2	chr10:27636298-27636725	l_277_chr10:27627368-27636725_testes
3	lnc-PTCHD3-2	chr10:27634694-27635239	l_277_chr10:27627368-27636725_testes
4	lnc-MASTL-2	chr10:27633668-27633846	ENSG00000260151.1
5	lnc-MASTL-2	chr10:27632365-27633580	ENSG00000260151.1
6	lnc-PTCHD3-2	chr10:27627369-27627692	l_277_chr10:27627368-27636725_testes

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	PTCHD3	hsa-miR-128-3p	chr10:27687123-27687143

Variant related genes	Relation type
FAM210CP	TF binding region
ENSG00000260151	TF binding region
TRIAP1P1	TF binding region
RNU6-452P	TF binding region
ENSG00000215409	TF binding region
FAM210CP	CpG island
ENSG00000260151	CpG island
TRIAP1P1	CpG island
RNU6-452P	CpG island
ENSG00000215409	CpG island
ENSG00000262412	chromatin interactions
ENSG00000182077	chromatin interactions
ENSG00000148459	chromatin interactions
ENSG00000107897	chromatin interactions
ENSG00000213770	chromatin interactions
ENSG00000099246	chromatin interactions
ENSG00000120539	chromatin interactions
ENSG00000136758	chromatin interactions

Extended variants
information (count: 2628 )
Associated
traits (count: 46 )

Variant overlapped rSNPs/rCNVs (count:2628 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs237601	chr10:27607905-27607906	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs546683061	chr10:27607915-27607916	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs112462937	chr10:27607961-27607962	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs113176734	chr10:27607977-27607978	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs375619746	chr10:27607979-27607980	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs552205271	chr10:27608002-27608003	Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs237602	chr10:27608013-27608014	Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs369619329	chr10:27608043-27608044	Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs559432052	chr10:27608048-27608049	Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs567453696	chr10:27608203-27608204	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs536370990	chr10:27608207-27608208	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs539524308	chr10:27608240-27608241	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs184567145	chr10:27608273-27608274	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs552622404	chr10:27608274-27608275	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs77893908	chr10:27608294-27608295	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs139003012	chr10:27608332-27608333	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs189259729	chr10:27608357-27608358	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs181626153	chr10:27608404-27608405	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs141859147	chr10:27608418-27608419	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs561082703	chr10:27608425-27608426	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs77476516	chr10:27608454-27608455	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs572717629	chr10:27608512-27608513	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs185855415	chr10:27608580-27608581	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs201181719	chr10:27608596-27608597	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs147103061	chr10:27608681-27608682	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs532050331	chr10:27608684-27608685	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs237603	chr10:27608687-27608688	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs565464981	chr10:27608696-27608697	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs531092515	chr10:27608740-27608741	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs550836886	chr10:27608822-27608823	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs567524847	chr10:27608826-27608827	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs12775266	chr10:27608838-27608839	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs78926816	chr10:27608843-27608844	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs7091630	chr10:27608855-27608856	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs7916462	chr10:27608975-27608976	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs181102752	chr10:27608995-27608996	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs7904595	chr10:27608999-27609000	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs186174174	chr10:27609079-27609080	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs554856168	chr10:27609103-27609104	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs535602086	chr10:27609118-27609119	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs58293608	chr10:27609134-27609135	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs56918749	chr10:27609139-27609140	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs57154451	chr10:27609146-27609147	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs7915661	chr10:27609152-27609153	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs59970014	chr10:27609161-27609162	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs61435137	chr10:27609167-27609168	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs61664405	chr10:27609184-27609185	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs76018769	chr10:27609188-27609189	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs190651819	chr10:27609262-27609263	Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs553630228	chr10:27609323-27609324	Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:46)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Autism	21439084	CNVD
Maculopathy	20981449	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21525872	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:450 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:27605000-27608000	Weak transcription	Primary neutrophils fromperipheralblood	blood
2	chr10:27608000-27608200	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr10:27608000-27608200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
4	chr10:27608000-27608400	Enhancers	GM12878-XiMat	blood
5	chr10:27608000-27608400	Enhancers	Monocytes-CD14+_RO01746	blood
6	chr10:27608000-27608600	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr10:27608000-27608600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
8	chr10:27608200-27608400	Enhancers	Primary B cells from cord blood	blood
9	chr10:27608200-27608400	Enhancers	Primary hematopoietic stem cells	blood
10	chr10:27608200-27608400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr10:27608200-27608400	Bivalent Enhancer	Brain Hippocampus Middle	brain
12	chr10:27608200-27608600	Enhancers	Breast Myoepithelial Primary Cells	Breast
13	chr10:27608200-27608600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
14	chr10:27608200-27608600	Enhancers	Primary hematopoietic stem cells short term culture	blood
15	chr10:27608200-27608600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr10:27608200-27608600	Enhancers	Fetal Intestine Large	intestine
17	chr10:27608200-27608600	Enhancers	Left Ventricle	heart
18	chr10:27608200-27608600	Enhancers	Right Ventricle	heart
19	chr10:27608200-27608800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
20	chr10:27608200-27609200	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr10:27608200-27609200	Enhancers	Primary B cells from peripheral blood	blood
22	chr10:27608200-27609200	Enhancers	Fetal Brain Male	brain
23	chr10:27608200-27609400	Enhancers	Esophagus	oesophagus
24	chr10:27608200-27609800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr10:27608400-27608600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
26	chr10:27608400-27608600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr10:27608400-27608600	Enhancers	Cortex derived primary cultured neurospheres	brain
28	chr10:27608400-27608600	Enhancers	Pancreatic Islets	Pancreatic Islet
29	chr10:27608400-27608600	Enhancers	Fetal Muscle Trunk	muscle
30	chr10:27608400-27608600	Enhancers	Hela-S3	cervix
31	chr10:27608400-27608600	Enhancers	HMEC	breast
32	chr10:27608400-27608800	Enhancers	Stomach Mucosa	stomach
33	chr10:27608400-27609000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
34	chr10:27608400-27609000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
35	chr10:27608400-27609000	Flanking Active TSS	Primary B cells from cord blood	blood
36	chr10:27608400-27609000	Active TSS	Fetal Kidney	kidney
37	chr10:27608400-27609000	Flanking Active TSS	GM12878-XiMat	blood
38	chr10:27608400-27609200	Active TSS	ES-I3 Cell Line	embryonic stem cell
39	chr10:27608400-27609200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
40	chr10:27608400-27609200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
41	chr10:27608400-27609200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr10:27608400-27609200	Flanking Active TSS	Primary hematopoietic stem cells	blood
43	chr10:27608400-27609200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr10:27608400-27609200	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
45	chr10:27608400-27609200	Active TSS	A549	lung
46	chr10:27608400-27609200	Flanking Active TSS	HUVEC	blood vessel
47	chr10:27608400-27609200	Active TSS	NH-A	brain
48	chr10:27608400-27609400	Enhancers	Fetal Heart	heart
49	chr10:27608400-27609400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
50	chr10:27608600-27608800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links